NOVEL CRYSTALLINE HETEROAROMATIC FLUOROGLYCOSIDE HYDRATES, PHARMACEUTICALS COMPRISING THESE COMPOUNDS AND THEIR USE

NOVEL CRYSTALLINE HETEROAROMATIC FLUOROGLYCOSIDE HYDRATES, PHARMACEUTICALS COMPRISING THESE COMPOUNDS AND THEIR USE

The invention relates to crystalline hydrates of the formula (I) in which n has a value of from 2.1 to 2.5. The compound is suitable, for example, as an antidiabetic. La invención se refiere a hidratos cristalinos de la fórmula I (ver fórmula (I)) en la cual n tiene un valor de 2,1 a 2,5. El compues...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVID RIGAL, BERND BECKER, NORBERT NAGEL, FRANCESKA FISCHER, MARTIN FETH, BRUNO BAUMGARTNER, MARTIN BROCKELMANN
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to crystalline hydrates of the formula (I) in which n has a value of from 2.1 to 2.5. The compound is suitable, for example, as an antidiabetic. La invención se refiere a hidratos cristalinos de la fórmula I (ver fórmula (I)) en la cual n tiene un valor de 2,1 a 2,5. El compuesto es adecuado, por ejemplo, como antidiabético.